Why has Jazz’s Vyxeos fallen short in sales? It may boil down to pricing and ‘politics’
The drug offers greater convenience and efficacy than the old chemotherapy combination, but its high cost and first impressions among doctors may explain why Jazz had to lower its sales guidance.